Fortem Capital Alternative Growth Fund

UK & EU – For professional and institutional investors only
Switzerland – this is an advertising document for professional and institutional clients as defined by the Swiss Financial Services Act only

Monthly Commentary – 30th November 2021

After a number of month’s in which COVID newsflow was muted, much to the benefit of risk assets, November was dominated first by increased infections in Europe and then the emergence of a new variant of concern; Omicron. In Europe, it was notable that hospitalisations increased more in those countries in which vaccine take up has been lower. It remains too early to tell whether the new variant significantly reduces the effectiveness of vaccines, but the early signs are encouraging on this front and early data suggests that although the variant is highly transmissible, it is relatively mild.

Inflation remained stubbornly high over the month; US CPI rose 6.2% from a year earlier in October. The perception that any further lockdowns may cause further supply chain disruption has meant that bond markets have been fairly erratic, yields fell heavily on the news of the new variant, before rising at the front end as it was suggested that there may be an acceleration in the US taper in spite of this.

The Fund increased by 0.9% over the month.

There were positive contributions from the majority of strategies.

The Fund’s long rates volatility strategies benefitted from heightened volatility in bond markets as investors grappled with inflation and the new variant. The risks to the bond market have been discussed often and at length, but perhaps what is likely, irrespective of the overall journey of travel for the bond market, is that there will be continued volatility along the way.

It was a positive month for the Fund’s commodity strategies which benefitted from some weakness in energy prices at the front of the curve. There was an element of this stemming from a move in oil timespreads as a result of the new variant, but the bigger impact came from a reversal of the moves seen in Natural Gas in September and October. In spite of the weakness in November, 75% of BCOM still remains in backwardation, suggesting there is still plenty to come from the strategies.

Total Return 2021 Nov
UK 100 13.0% -2.2%
US 500 22.7% -0.7%
Europe 50 16.6% -4.3%
Japan 225 2.6% -3.7%
Hong Kong 50 -11.7% -7.4%
US 2000 12.3% -4.2%
Swiss 30 16.9% 0.4%
BCOM 22.7% -7.3%
US Treasury -1.3% 0.3%
FTSE EPRA 23.6% 3.2%
PGF 6.0% -1.3%
AGF -0.5% 0.9%
Real Estate 20.1% 0.9%
US Equity Income n/a -0.8%

Disclaimer

– This document has been issued and approved as a financial promotion by Fortem Capital Limited for the purpose of section 21 of the Financial Services and Markets Acts 2000. Fortem Capital Limited registration number 10042702 is authorised and regulated by the Financial Conduct Authority under firm reference number 755370.
– This document is intended for Professional Investors, Institutional Clients and Advisors and should not be communicated to any other person.
– The information has been prepared solely for information purposes only and is not an offer or solicitation of an offer to buy or sell the product.
– Data is sourced from Fortem Capital Limited and external sources. The data is as at the date of this document and has been reviewed by Fortem Capital Limited.
– Information, including prices, analytical data and opinions contained within this document are believed to be correct, accurate and derived from reliable sources as at the date of the document. However, no representation or warranty, expressed or implied is made as to the correctness, accuracy or validity of such information.
– Fortem Capital Limited assumes

no responsibility or
liability for any errors, omissions or inaccuracy with respect to the information contained within this document.
– All price and analytical data included in this document is
intended for indicative purposes only and is as at the date
of the document.
– The information within this document does not take into account the specific investment objective or financial situation of any person. Investors should refer to the final documentation and any prospectus to ascertain all of the risks and terms associated with these securities and seek independent advice, where necessary, before making any decision to buy or sell.
– The product may not be offered, sold, transferred or delivered directly or indirectly in the United States to, or for the account or benefit of, any U.S. Person.
– The Fortem Capital Alternative Growth Fund is a Sub-Fund of Skyline, an open-ended investment company with variable capital incorporated on 1 June 2010 with limited liability under the laws of Ireland with segregated liability between Funds. The Company is authorised in Ireland by the Central Bank of Ireland pursuant to the UCITS Regulations.

“NOTICE TO INVESTORS DOMICILED OR RESIDENT IN SWITZERLAND – The interests in the UCITS Fund and any related services, information and opinions described or referenced in this document are not, and may not be, offered or marketed to or directed at persons in Switzerland (a) that do not meet the definition of “qualified investor" pursuant to the Swiss Federal Act on Collective Investment Schemes of 23 June 2006 (“CISA") (“Non-Qualified Investors"), or (b) that are high net worth individuals (including private investment structures established for such high-net worth individuals if they do not have professional treasury operations) that have opted out of customer protection under the Swiss Federal Financial Services Act of 15 June 2018 (“FinSA") and that have elected to be treated as “professional clients" and “qualified investors" under the FinSA and the CISA, respectively (“Elective Qualified Investors").
In particular, none of the information provided in this document should be construed as an offer in Switzerland

for the purchase or sale of the interests or any related services, nor as advertising in Switzerland for the interests or any related services, to or directed at Non-Qualified Investors or Elective Qualified Investors. Circulating or otherwise providing access to this document or offering, advertising or selling the interests or any related services to Non-Qualified Investors or Elective Qualified Investors may trigger, in particular, approval requirements and other regulatory requirements in Switzerland.
This document does not constitute a prospectus pursuant to Articles 35 et seqq. FinSA and may not fulfil the information standards established thereunder. No key information document pursuant to Swiss law has been established for the interests. The interests will not be listed or admitted to trading on a Swiss trading venue and, consequently, the information presented in this document may not fulfil the information standards set out in the relevant trading venue rules."